Rayno Biopharmaceutical Stocks-CBST Up 35%
Update 12/8 Biotech stocks hit new highs yesterday but could get choppy if overall market gets weak on bleak macro news. Cubist Pharmaceuticals (CBST) one of our original mid cap Biopharmaceutical picks soared 35% today to $100.75 on a $8.4B buyout by Merck (MRK).
Cruise Control Till Year End
Update 12/12 Or Maybe NOT!! Jobs data tomorrow and most funds will ride their positions through year end. In the meantime it is a traders market. Update next week but review all our portfolio picks.
Biotech Stocks Hit By Profit Taking-More Volatility Lies Ahead…Update-1
Bounce Back Day 12/2/14 FBT up 1.5% to $102.33 Biotech players realized that news about China, energy and holiday shopping data do not affect their stocks. Our large cap biopharma portfolio went green helped by Biogen Idec (BIIB) up 6.43% on Phase 1a data for an Alzheimer Diseases drug!...
Rayno Life Science: Market Update 11/26… Stocks Cruise To New Highs
NASDAQ leads -up 0.6% to 4787 The October correction of ~7% was a “headfake” as macro events scared many investor away Technology and Healthcare Stocks Lead The Way The healthcare SPDR (XLV) is up 24.5% YTD and the technology SPDR (XLK) is up 18% YTD. Biotech stocks are at new highs...
Sierra SnowBlog: Nov. 26, 2014 Significant Storm on the Way…Update-1
Update 12/3 Much Needed Heavy Rain Comes To SoCal but Mammoth Gets Only~20 in Wet Snow Warm Weather Storm Hits The Coast The Mammoth snowman posted at 8 am and says the really big part of the storm headed North.A wet storm should help get us a good base. Mammoth Mountain Snowman Report...
